Author

Ludovica Gaiaschi

Brigham and Women's HospitalORCID 0000-0002-1880-2277Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Benjamin Scott· 1 shared Choi‐Fong ChoiD· 1 shared Eric Shusta· 1 shared Fengfeng BeiiD· 1 shared Jorge L. Jimenez-MaciasiD· 1 shared Martine L.M. LamfersiD· 1 shared Pei ZhuangiD· 1 shared Rui YiniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Benjamin Scott

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High-throughput glioblastoma-neurovascular assembloids model blood-tumor barrier disruption, tumor reprogramming and therapeutic efficacy

Pei Zhuang, Shuai Gao, Benjamin Scott, Yibo Jia, Wei-Min Meng, Rui Yin, Xinyu Nie, Soniya Tamhankar, Sean P. Palecek, Ludovica Gaiaschi, Jorge L. Jimenez-Macias, Shuichi Mizuno, Sean Edward Lawler, Eric Shusta, Martine L.M. Lamfers, , Choi‐Fong Cho

This paper develops a high-throughput BTB assembloid model to study glioblastoma-neurovascular interactions and therapeutic responses, finding that BTB disruption correlates with increased tumor invasiveness and drug resistance.

bioRxiv · Nov 11, 2024 · PreprintBioengineering